Qube Research & Technologies (QRT)’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.43K | Hold |
53
| – | – | ﹤0.01% | 2652 |
|
2025
Q1 | $2.55K | Hold |
53
| – | – | ﹤0.01% | 2636 |
|
2024
Q4 | $2.69K | Hold |
53
| – | – | ﹤0.01% | 2601 |
|
2024
Q3 | $3.38K | Hold |
53
| – | – | ﹤0.01% | 2614 |
|
2024
Q2 | $3.14K | Sell |
53
-414
| -89% | -$24.5K | ﹤0.01% | 2730 |
|
2024
Q1 | $26.9K | Hold |
467
| – | – | ﹤0.01% | 3124 |
|
2023
Q4 | $26.6K | Sell |
467
-26
| -5% | -$1.48K | ﹤0.01% | 3013 |
|
2023
Q3 | $23.7K | Sell |
493
-1,179
| -71% | -$56.6K | ﹤0.01% | 2669 |
|
2023
Q2 | $76.3K | Buy |
1,672
+1,621
| +3,178% | +$74K | ﹤0.01% | 1925 |
|
2023
Q1 | $2.76K | Sell |
51
-27
| -35% | -$1.46K | ﹤0.01% | 2374 |
|
2022
Q4 | $4.5K | Sell |
78
-305
| -80% | -$17.6K | ﹤0.01% | 2269 |
|
2022
Q3 | $18K | Buy |
383
+129
| +51% | +$6.06K | ﹤0.01% | 2263 |
|
2022
Q2 | $12K | Buy |
+254
| New | +$12K | ﹤0.01% | 2295 |
|
2022
Q1 | – | Sell |
-1,368
| Closed | -$111K | – | 2438 |
|
2021
Q4 | $111K | Buy |
+1,368
| New | +$111K | ﹤0.01% | 2121 |
|